{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:05:45Z","timestamp":1783533945826,"version":"3.55.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,2,21]]},"abstract":"<jats:p>This JAMA Patient Page describes the autoimmune disease Guillain-Barr\u00e9 syndrome and its risk factors, diagnosis, treatment, and prognosis.<\/jats:p>","DOI":"10.1001\/jama.2022.24232","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T16:02:13Z","timestamp":1675353733000},"page":"602","source":"Crossref","is-referenced-by-count":9,"title":["What Is Guillain-Barr\u00e9 Syndrome?"],"prefix":"10.1001","volume":"329","author":[{"given":"Revital","family":"Marcus","sequence":"first","affiliation":[{"name":"Fishbein Fellow, JAMA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2801220\/jama_marcus_2023_pg_220048_1676478924.2109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:15:47Z","timestamp":1676996147000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2801220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,2,21]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.24232","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}